RGEN

Repligen Stock Price

219.32
2.41 (1.11%)
Upgrade to Real-Time
Afterhours (Closed)
219.32
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Repligen Corp RGEN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
2.41 1.11% 219.32 20:00:00
Open Price Low Price High Price Close Price Prev Close
216.54 216.142 219.44 219.32 216.91
Bid Price Ask Price Spread News
216.10 220.00 3.90 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
6,160 172,749 $ 218.09 $ 37,674,636 430,576 78.41 - 226.97
Last Trade Time Type Quantity Stock Price Currency
18:21:53 3 $ 219.40 USD

Repligen Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 12.00B 54.72M 48.67M $ 270.25M $ 42.21M 0.44 264.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% -461.00 4.60%

more financials information »

Repligen News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RGEN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week213.00226.97212.395218.16454,5216.322.97%
1 Month198.00226.97182.90205.59349,65221.3210.77%
3 Months169.43226.97163.55193.68437,11149.8929.45%
6 Months135.99226.97131.91172.30407,24483.3361.28%
1 Year101.47226.9778.41135.72494,886117.85116.14%
3 Years35.98226.9729.5693.48434,143183.34509.56%
5 Years23.23226.9720.0775.68371,825196.09844.12%

Repligen Description

Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in the United States.


Your Recent History
NASDAQ
RGEN
Repligen
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.